IPO registrations (S-1, F-1) · Registrants
Centogene N.V.
- SEC CIK
- 1757097 · filings on EDGAR ↗
- Former names
- Centogene B.V. (2018–2019)
- Registration
- Form F-1, first filed 2019-10-11, last 2020-07-07; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2019-11-08; declared effective 2019-11-06
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- P7
- Business address
- AM STRANDE 7, Rostock, 2M 18055
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $14.00–$16.00 per share (F-1/A filed 2019-10-28)
- Final price
- $14.00 per share, within the range (424B4 filed 2019-11-08, an initial public offering)
- Shares sold
- 4,000,000
- Gross proceeds
- $56,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CNTG
- Lead underwriters
- Leerink Partners; Evercore
- Syndicate
- Baird; BTIG
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-10-11 | F-1 | F-1 (foreign registration) | Centogene B.V. | 0001047469-19-005715 ↗ |
| 2019-10-28 | F-1/A | F-1/A (amendment) | Centogene B.V. | 0001047469-19-005919 ↗ |
| 2019-11-06 | EFFECT | EFFECT (declared effective) | Centogene B.V. | 9999999995-19-002504 ↗ |
| 2019-11-08 | 424B4 | 424B4 (final prospectus) | Centogene B.V. | 0001047469-19-006180 ↗ |
| 2020-07-07 | F-1 | F-1 (foreign registration) | Centogene N.V. | 0001047469-20-004012 ↗ |
| 2020-07-09 | EFFECT | EFFECT (declared effective) | Centogene N.V. | 9999999995-20-001751 ↗ |
| 2020-07-10 | 424B4 | 424B4 (final prospectus) | Centogene N.V. | 0001047469-20-004069 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-10-28 | F-1/A | registration statement | $14.00–$16.00 | $15.00 | 4,000,000 | $60,000,000 | Nasdaq CNTG | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2019-11-08 | 424B4 | final prospectus | $14.00 | 4,000,000 | $56,000,000 | Nasdaq CNTG | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Services-Medical Laboratories, 2M first:
- Med BioGene Inc. A1
- DYNACARE INC A6
- GenEmbryomics Ltd C3
- MDxHealth SA C9
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- GENOMIC HEALTH INC CA
- PERLEGEN SCIENCES, INC. CA
In other datasets, the same topic (Health) in 2M:
- Form D issuer: ATAI Life Sciences AG (Form D private offerings)
Interests: Services-Medical Laboratories · Health